84.11
전일 마감가:
$84.70
열려 있는:
$84.19
하루 거래량:
9.15M
Relative Volume:
0.76
시가총액:
$210.09B
수익:
$63.43B
순이익/손실:
$16.42B
주가수익비율:
12.97
EPS:
6.4861
순현금흐름:
$14.72B
1주 성능:
-2.65%
1개월 성능:
+3.81%
6개월 성능:
+7.30%
1년 성능:
-24.59%
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
MRK을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
MRK
Merck Co Inc
|
84.11 | 211.56B | 63.43B | 16.42B | 14.72B | 6.4861 |
![]()
LLY
Lilly Eli Co
|
826.57 | 728.24B | 53.26B | 13.80B | -50.20M | 15.08 |
![]()
JNJ
Johnson Johnson
|
191.17 | 459.63B | 92.15B | 25.12B | 18.18B | 10.36 |
![]()
ABBV
Abbvie Inc
|
226.22 | 404.77B | 58.33B | 3.73B | 18.24B | 2.1013 |
![]()
NVS
Novartis Ag Adr
|
129.97 | 252.16B | 53.40B | 13.68B | 16.89B | 6.8864 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
2024-12-10 | 재개 | BofA Securities | Buy |
2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
2024-11-15 | 개시 | Wolfe Research | Peer Perform |
2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
2024-10-17 | 개시 | Bernstein | Mkt Perform |
2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
2023-11-09 | 개시 | Deutsche Bank | Buy |
2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
2023-07-14 | 개시 | HSBC Securities | Hold |
2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2023-03-06 | 개시 | Jefferies | Buy |
2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
2022-11-18 | 개시 | Credit Suisse | Outperform |
2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
2022-06-06 | 재개 | SVB Leerink | Outperform |
2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
2021-12-17 | 개시 | Goldman | Buy |
2021-12-16 | 개시 | Daiwa Securities | Neutral |
2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
2021-12-09 | 개시 | Wells Fargo | Overweight |
2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
2021-11-01 | 업그레이드 | Argus | Hold → Buy |
2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-07-27 | 재개 | Truist | Buy |
2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
2020-11-10 | 재개 | Bernstein | Outperform |
2020-09-29 | 개시 | Berenberg | Hold |
2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
2020-02-27 | 개시 | Barclays | Overweight |
2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
2019-10-17 | 재개 | BofA/Merrill | Neutral |
2019-08-16 | 개시 | SVB Leerink | Outperform |
2019-07-03 | 개시 | Mizuho | Buy |
2019-05-28 | 개시 | Goldman | Neutral |
2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
2018-10-16 | 재확인 | Citigroup | Buy |
2018-10-09 | 재개 | Guggenheim | Buy |
2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Why Moderna Might Be a One-Hit Wonder - The Motley Fool
Merck: A Golden Buying Opportunity (NYSE:MRK) - Seeking Alpha
Merck's New HIV Treatment Works As Well As Top Drug In Late Trials - Benzinga
Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infection - FinancialContent
Generali Asset Management SPA SGR Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
RFG Advisory LLC Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Position Trimmed by Sagespring Wealth Partners LLC - MarketBeat
TD Asset Management Inc Sells 240,683 Shares of Merck & Co., Inc. $MRK - MarketBeat
Envestnet Portfolio Solutions Inc. Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Boston Trust Walden Corp Purchases 37,557 Shares of Merck & Co., Inc. $MRK - MarketBeat
Courier Capital LLC Sells 8,424 Shares of Merck & Co., Inc. $MRK - MarketBeat
Morningstar Investment Management LLC Acquires Shares of 10,924 Merck & Co., Inc. $MRK - MarketBeat
Vest Financial LLC Buys 20,838 Shares of Merck & Co., Inc. $MRK - MarketBeat
Atria Wealth Solutions Inc. Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Pzena Investment Management LLC Buys New Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by MGO One Seven LLC - MarketBeat
Merck & Co. Earnings Preview: What to Expect - MSN
Merck & Co. Earnings Preview: What To Expect - Barchart.com
Merck: An Undervalued Stock In An Expensive Market - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Earns Neutral Rating from Citigroup - MarketBeat
Almanack Investment Partners LLC. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
NorthRock Partners LLC Buys 6,614 Shares of Merck & Co., Inc. $MRK - MarketBeat
Verdence Capital Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by MOKAN Wealth Management Inc. - MarketBeat
Sequoia Financial Advisors LLC Has $23.68 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Stack Financial Management Inc Sells 4,025 Shares of Merck & Co., Inc. $MRK - MarketBeat
Johnson Investment Counsel Inc. Sells 11,817 Shares of Merck & Co., Inc. $MRK - MarketBeat
GW Henssler & Associates Ltd. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Legal Advantage Investments Inc. Acquires 5,040 Shares of Merck & Co., Inc. $MRK - MarketBeat
SPC Financial Inc. Sells 4,577 Shares of Merck & Co., Inc. $MRK - MarketBeat
OFI Invest Asset Management Has $56.68 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Orca Investment Management LLC Buys Shares of 18,466 Merck & Co., Inc. $MRK - MarketBeat
Cwm LLC Purchases 140,163 Shares of Merck & Co., Inc. $MRK - MarketBeat
Advocate Group LLC Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Makes New $3.20 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Vanguard Personalized Indexing Management LLC - MarketBeat
Merck & Co. Inc. (MRK): Billionaire D.E. Shaw Is Bullish On This Stock Right Now - MSN
Merck & Co., Inc. $MRK Shares Purchased by waypoint wealth counsel - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by GFS Advisors LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Fifth Third Wealth Advisors LLC - MarketBeat
Aberdeen Group plc Buys 12,338 Shares of Merck & Co., Inc. $MRK - MarketBeat
Eastern Bank Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Agate Pass Investment Management LLC - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Unloaded Rep. Val T. Hoyle - MarketBeat
Robertson Stephens Wealth Management LLC Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Ramirez Asset Management Inc. Sells 14,666 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Callan Family Office LLC - MarketBeat
UK Weighs 25% Rise In Drug Prices As Pharma Giants Pause Investments - Benzinga
JB Capital LLC Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Cascade Investment Group Inc. Acquires New Shares in Merck & Co., Inc. $MRK - MarketBeat
Commerzbank Aktiengesellschaft FI Has $15.70 Million Position in Merck & Co., Inc. $MRK - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):